“On the basis of a rate of death from any cause at 1 year that was 20 percentage points lower with TAVI than with standard therapy, balloon-expandable TAVI should be the new standard of care for patients with aortic stenosis who are not suitable candidates for surgery.”
–The PARTNER Trial Investigators1
The magnitude of improvement in quality of life scores with TAVI was roughly equivalent to a 10-year reduction in age.2
Among inoperable patients with severe AS, TAVI conferred a 25-point improvement in the KCCQ quality of life score after one year.2
* Patients in control arm received best medical management which frequently (78.2%) included balloon aortic valvuloplasty
Any quotes used in this material are taken from independent third-party publications and are not intended to imply that such third party reviewed or endorsed any of the products of Edwards Lifesciences.
See instructions for use for full prescribing information, including indications, contraindications, warnings, precautions and adverse event.
Edwards Lifesciences devices placed on the European market meeting the essential requirements referred to in Article 3 of the Medical Device Directive 93/42/EEC bear the CE marking of conformity.
Please update to a current version of your preferred browser, this site will perform effectively on the following:Unable to update your browser?
If you are on a computer, that is maintained by an admin and you cannot install a new browser, ask your admin about it. If you can't change your browser because of compatibility issues, think about installing a second browser for browsing and keep this old one for compatibility